Studies on the effect of CL 306,293, a substituted quinoline carboxylic acid, on the clinical disease induced in mice with LP-BM5 virus

Jeffery W. Scott, Susan Quinn DeJoy, Robert Jeyaseelan, Dennis W. Powell, Carmen Raventos-Suarez, Bryan O'Hara, Michael M. Wick, Arnold L. Oronsky, S. S. Kerwar

Research output: Contribution to journalArticle

Abstract

CL 306,293, a substituted quinoline carboxylic acid, is a potent inhibitor of dihydroorotic acid dehydrogenase, an enzyme essential for the biosynthesis of pyrimidines. In mammalian cell culture, the agent exhibits antiproliferative properties that can be reversed by the addition of uridine. CL 306,293 inhibits the development of the clinical disease in a murine model of immunodeficiency induced by a mixture of LP-BM5 retroviruses. In infected mice, the agent prevents the development of hypergammaglobulinemia, lymphadenopathy, splenomegaly and induction of an IL-2 deficiency. The CD4/CD8 ratio and the number of B cells in the lymph nodes are decreased if the infected animals are treated with CL 306,293. CL 306,293 was more efficacious and potent than 3′-azido-3′-deoxythymidine. The beneficial effects of CL 306,293 observed in this model are most probably related to its antiproliferative properties.

Original languageEnglish (US)
Pages (from-to)71-81
Number of pages11
JournalAntiviral Research
Volume20
Issue number1
DOIs
StatePublished - 1993
Externally publishedYes

Fingerprint

Carboxylic Acids
Viruses
Hypergammaglobulinemia
Pyrimidines
CD4-CD8 Ratio
Zidovudine
Uridine
Splenomegaly
Retroviridae
Interleukin-2
Oxidoreductases
B-Lymphocytes
Cell Culture Techniques
Lymph Nodes
quinoline
3-amino-2-(1,1'-biphenyl)-4-yl-6-fluoro-4-quinolinecarboxylic acid
Acids
Enzymes

Keywords

  • AIDS
  • Antimetabolite
  • Antiproliferative
  • Azidothymidine
  • CL 306,293
  • Dihydroorotic acid dehydrogenase inhibitor
  • LP-BM5 retrovirus
  • MAIDS
  • MuLV

ASJC Scopus subject areas

  • Virology
  • Pharmacology

Cite this

Scott, J. W., DeJoy, S. Q., Jeyaseelan, R., Powell, D. W., Raventos-Suarez, C., O'Hara, B., ... Kerwar, S. S. (1993). Studies on the effect of CL 306,293, a substituted quinoline carboxylic acid, on the clinical disease induced in mice with LP-BM5 virus. Antiviral Research, 20(1), 71-81. https://doi.org/10.1016/0166-3542(93)90060-V

Studies on the effect of CL 306,293, a substituted quinoline carboxylic acid, on the clinical disease induced in mice with LP-BM5 virus. / Scott, Jeffery W.; DeJoy, Susan Quinn; Jeyaseelan, Robert; Powell, Dennis W.; Raventos-Suarez, Carmen; O'Hara, Bryan; Wick, Michael M.; Oronsky, Arnold L.; Kerwar, S. S.

In: Antiviral Research, Vol. 20, No. 1, 1993, p. 71-81.

Research output: Contribution to journalArticle

Scott, JW, DeJoy, SQ, Jeyaseelan, R, Powell, DW, Raventos-Suarez, C, O'Hara, B, Wick, MM, Oronsky, AL & Kerwar, SS 1993, 'Studies on the effect of CL 306,293, a substituted quinoline carboxylic acid, on the clinical disease induced in mice with LP-BM5 virus', Antiviral Research, vol. 20, no. 1, pp. 71-81. https://doi.org/10.1016/0166-3542(93)90060-V
Scott, Jeffery W. ; DeJoy, Susan Quinn ; Jeyaseelan, Robert ; Powell, Dennis W. ; Raventos-Suarez, Carmen ; O'Hara, Bryan ; Wick, Michael M. ; Oronsky, Arnold L. ; Kerwar, S. S. / Studies on the effect of CL 306,293, a substituted quinoline carboxylic acid, on the clinical disease induced in mice with LP-BM5 virus. In: Antiviral Research. 1993 ; Vol. 20, No. 1. pp. 71-81.
@article{fd533a04626044ec9084332c0281e0b1,
title = "Studies on the effect of CL 306,293, a substituted quinoline carboxylic acid, on the clinical disease induced in mice with LP-BM5 virus",
abstract = "CL 306,293, a substituted quinoline carboxylic acid, is a potent inhibitor of dihydroorotic acid dehydrogenase, an enzyme essential for the biosynthesis of pyrimidines. In mammalian cell culture, the agent exhibits antiproliferative properties that can be reversed by the addition of uridine. CL 306,293 inhibits the development of the clinical disease in a murine model of immunodeficiency induced by a mixture of LP-BM5 retroviruses. In infected mice, the agent prevents the development of hypergammaglobulinemia, lymphadenopathy, splenomegaly and induction of an IL-2 deficiency. The CD4/CD8 ratio and the number of B cells in the lymph nodes are decreased if the infected animals are treated with CL 306,293. CL 306,293 was more efficacious and potent than 3′-azido-3′-deoxythymidine. The beneficial effects of CL 306,293 observed in this model are most probably related to its antiproliferative properties.",
keywords = "AIDS, Antimetabolite, Antiproliferative, Azidothymidine, CL 306,293, Dihydroorotic acid dehydrogenase inhibitor, LP-BM5 retrovirus, MAIDS, MuLV",
author = "Scott, {Jeffery W.} and DeJoy, {Susan Quinn} and Robert Jeyaseelan and Powell, {Dennis W.} and Carmen Raventos-Suarez and Bryan O'Hara and Wick, {Michael M.} and Oronsky, {Arnold L.} and Kerwar, {S. S.}",
year = "1993",
doi = "10.1016/0166-3542(93)90060-V",
language = "English (US)",
volume = "20",
pages = "71--81",
journal = "Antiviral Research",
issn = "0166-3542",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Studies on the effect of CL 306,293, a substituted quinoline carboxylic acid, on the clinical disease induced in mice with LP-BM5 virus

AU - Scott, Jeffery W.

AU - DeJoy, Susan Quinn

AU - Jeyaseelan, Robert

AU - Powell, Dennis W.

AU - Raventos-Suarez, Carmen

AU - O'Hara, Bryan

AU - Wick, Michael M.

AU - Oronsky, Arnold L.

AU - Kerwar, S. S.

PY - 1993

Y1 - 1993

N2 - CL 306,293, a substituted quinoline carboxylic acid, is a potent inhibitor of dihydroorotic acid dehydrogenase, an enzyme essential for the biosynthesis of pyrimidines. In mammalian cell culture, the agent exhibits antiproliferative properties that can be reversed by the addition of uridine. CL 306,293 inhibits the development of the clinical disease in a murine model of immunodeficiency induced by a mixture of LP-BM5 retroviruses. In infected mice, the agent prevents the development of hypergammaglobulinemia, lymphadenopathy, splenomegaly and induction of an IL-2 deficiency. The CD4/CD8 ratio and the number of B cells in the lymph nodes are decreased if the infected animals are treated with CL 306,293. CL 306,293 was more efficacious and potent than 3′-azido-3′-deoxythymidine. The beneficial effects of CL 306,293 observed in this model are most probably related to its antiproliferative properties.

AB - CL 306,293, a substituted quinoline carboxylic acid, is a potent inhibitor of dihydroorotic acid dehydrogenase, an enzyme essential for the biosynthesis of pyrimidines. In mammalian cell culture, the agent exhibits antiproliferative properties that can be reversed by the addition of uridine. CL 306,293 inhibits the development of the clinical disease in a murine model of immunodeficiency induced by a mixture of LP-BM5 retroviruses. In infected mice, the agent prevents the development of hypergammaglobulinemia, lymphadenopathy, splenomegaly and induction of an IL-2 deficiency. The CD4/CD8 ratio and the number of B cells in the lymph nodes are decreased if the infected animals are treated with CL 306,293. CL 306,293 was more efficacious and potent than 3′-azido-3′-deoxythymidine. The beneficial effects of CL 306,293 observed in this model are most probably related to its antiproliferative properties.

KW - AIDS

KW - Antimetabolite

KW - Antiproliferative

KW - Azidothymidine

KW - CL 306,293

KW - Dihydroorotic acid dehydrogenase inhibitor

KW - LP-BM5 retrovirus

KW - MAIDS

KW - MuLV

UR - http://www.scopus.com/inward/record.url?scp=0027535650&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027535650&partnerID=8YFLogxK

U2 - 10.1016/0166-3542(93)90060-V

DO - 10.1016/0166-3542(93)90060-V

M3 - Article

C2 - 8384434

AN - SCOPUS:0027535650

VL - 20

SP - 71

EP - 81

JO - Antiviral Research

JF - Antiviral Research

SN - 0166-3542

IS - 1

ER -